Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents
The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each p...
Uloženo v:
| Vydáno v: | Journal of general virology Ročník 79 ( Pt 5); s. 1027 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
01.05.1998
|
| Témata: | |
| ISSN: | 0022-1317 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins. |
|---|---|
| AbstractList | The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins.The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins. The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early promoter in a replication-deficient adenovirus vector. Immunofluorescence and radioimmune precipitation demonstrated the synthesis of each protein and biological activity was confirmed by the detection of haemadsorption and fusion activities in infected cells. Oral as well as parenteral administration of the H-expressing recombinant adenovirus elicited a significant protective response in mice challenged with MV. While the F-expressing adenovirus failed to protect mice, cotton rats immunized with either the H- or F-expressing recombinant showed reduced MV replication in the lungs. Antibodies elicited in mice following immunization with either recombinant had no in vitro neutralizing activity, suggesting a protective mechanism involving a cell-mediated immune response. This study demonstrates the feasibility of using oral administration of adenovirus recombinants to induce protective responses to heterologous proteins. |
| Author | Jeevarajah, D Clegg, J C Lee, J Fooks, A R ter Meulen, V Niewiesk, S Stephenson, J R Warnes, A |
| Author_xml | – sequence: 1 givenname: A R surname: Fooks fullname: Fooks, A R email: anthony.fooks@camr.org.uk organization: Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK. anthony.fooks@camr.org.uk – sequence: 2 givenname: D surname: Jeevarajah fullname: Jeevarajah, D – sequence: 3 givenname: J surname: Lee fullname: Lee, J – sequence: 4 givenname: A surname: Warnes fullname: Warnes, A – sequence: 5 givenname: S surname: Niewiesk fullname: Niewiesk, S – sequence: 6 givenname: V surname: ter Meulen fullname: ter Meulen, V – sequence: 7 givenname: J R surname: Stephenson fullname: Stephenson, J R – sequence: 8 givenname: J C surname: Clegg fullname: Clegg, J C |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9603317$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9UMtOwzAQ9KGotMAXICSfuBn8SJOYG6p4SZV6gXPkxJvWKLGD7VTwVfwi7kOcdnd2dma0czSxzgJC14zeMSrlPaWcEyZYQQpJFoRRXkzQ7B89R_MQPillWbYopmgqcyoSPEO_a6867DwelAcbYT8p3RtrQvQqGmexa7GHoTPNYSQaWtOYxE08sG5n_BggYPgePIRg7AbHLeAeVOgSfFjjrYJebTbdGJOwxcpq3I5hLz54F8HY8HDsmmh2gE3fjxaSaxic3YunG--SWwyX6KxVXYCrU71AH89P78tXslq_vC0fV6QReRZJzUCXZVvTXJdapsgyL6TWedkKAbrQgrdKLHidZVK3QmuQIv2D1znnlOaS8Qt0e9RNsb5GCLHqTWig65QFN4aqkKVkZZkn4s2JONY96Grwplf-pzp9mP8BSGGElA |
| CitedBy_id | crossref_primary_10_3390_v14030520 crossref_primary_10_1128_CMR_17_2_465_493_2004 crossref_primary_10_1016_j_apsb_2024_08_026 crossref_primary_10_1006_viro_2001_1240 crossref_primary_10_1016_S1359_6446_00_01600_7 crossref_primary_10_1111_tbed_13936 crossref_primary_10_1016_j_ymthe_2004_07_013 crossref_primary_10_1186_1743_422X_8_268 crossref_primary_10_1006_viro_2001_0945 crossref_primary_10_1016_S0020_7519_03_00062_6 crossref_primary_10_1016_S0264_410X_00_00452_7 crossref_primary_10_1128_JVI_74_19_9083_9089_2000 crossref_primary_10_1016_j_micinf_2005_05_023 crossref_primary_10_1016_j_vaccine_2010_09_055 crossref_primary_10_1016_S0165_2478_98_00123_0 crossref_primary_10_1586_14760584_1_2_151 crossref_primary_10_1016_S0928_0197_98_00038_5 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1099/0022-1317-79-5-1027 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| ExternalDocumentID | 9603317 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 .GJ 186 18M 2WC 39C 3O- 4.4 53G 5GY 5RE AAJMC ABDNZ ACBTR ACGFO ACPEE ACYGS ADBBV ADCDP ADCOW AEILP AENEX AFFNX AGCDD AI. AJKYU ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CGR CJ0 CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 K-O L7B NPM OHT OK1 P2P PKN RGM TR2 VH1 W8F WH7 WHG WOQ X7M Y6R YKV YSK ZGI ~KM 7X8 |
| ID | FETCH-LOGICAL-c364t-b1ed88fb06d8d9def9679dd68f33ed7d32fa352b449df3dde933312b622006912 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 31 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000073436400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0022-1317 |
| IngestDate | Fri Jul 11 06:55:53 EDT 2025 Wed Feb 19 01:18:20 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c364t-b1ed88fb06d8d9def9679dd68f33ed7d32fa352b449df3dde933312b622006912 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 9603317 |
| PQID | 79891886 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_79891886 pubmed_primary_9603317 |
| PublicationCentury | 1900 |
| PublicationDate | 1998-05-01 |
| PublicationDateYYYYMMDD | 1998-05-01 |
| PublicationDate_xml | – month: 05 year: 1998 text: 1998-05-01 day: 01 |
| PublicationDecade | 1990 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Journal of general virology |
| PublicationTitleAlternate | J Gen Virol |
| PublicationYear | 1998 |
| SSID | ssj0014457 |
| Score | 1.709393 |
| Snippet | The genes encoding the measles virus (MV) haemagglutinin (H) and fusion (F) proteins were placed under the control of the human cytomegalovirus immediate early... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1027 |
| SubjectTerms | Adenoviridae - physiology Administration, Oral Animals Antibodies, Viral - immunology Cell Line Cell Line, Transformed Defective Viruses - physiology Female Genetic Vectors Hemagglutinins, Viral - genetics Hemagglutinins, Viral - immunology Humans Injections, Intraperitoneal Measles - prevention & control Measles Vaccine - immunology Measles virus - immunology Mice Mice, Inbred BALB C Mice, Inbred C3H Rats Sigmodontinae Viral Fusion Proteins - genetics Viral Fusion Proteins - immunology Virus Replication |
| Title | Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/9603317 https://www.proquest.com/docview/79891886 |
| Volume | 79 ( Pt 5) |
| WOSCitedRecordID | wos000073436400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA4-wYtvcX3m4DVs28QmEUFEXLy47kFhb0uySdaCptq6i_4q_6KTdrviQTx4KTSPJnSmX6aZyTcInTBYxa3SjighHGFacyLV0BChFTORc6lQuko2wbtd0e_L3hw6b87ChLDKBhMroDb5MOyRt7kUMhYivXh5JSFnVPCtThNozKNFCoZM0Gne__YhMHbKG67wGJbJhnNIyvasjHBJAhNnwn-3MKuVprP2vzmuo9WphYkva5XYQHPWb6LlOufkxxb6vCugNi9wCD0PbxXu1A8GXZw7XNiZX5sYG1gmoC20sz6fZMW4tCW273UMrR9hMCLxs1XlExRX1fhR2Wc1GgW19pnHyhvsxmFjDlfEEJkvz_CUIgLgFmfhlIqFUauAXXgK9AFkD0Ee2-ihc31_dUOmWRvIkKbsjejYGpC7jlIjjIQpypRLY1LhKLWGG5o4BVafZkwaRwFdJaU0TnSahN0NGSc7aMHn3u4iHGkWCU1FwlLF4hj0BtCEAQRFQvJExS103MhhAF9FcHUob_NxOWgk0UI7tSgHLzV5xwD-2GA4vvdn1320Up8_DMGNB2jRARzYQ7Q0nLxlZXFU6Rpcu73bLxwL5FQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+or+parenteral+administration+of+replication-deficient+adenoviruses+expressing+the+measles+virus+haemagglutinin+and+fusion+proteins%3A+protective+immune+responses+in+rodents&rft.jtitle=Journal+of+general+virology&rft.au=Fooks%2C+A+R&rft.au=Jeevarajah%2C+D&rft.au=Lee%2C+J&rft.au=Warnes%2C+A&rft.date=1998-05-01&rft.issn=0022-1317&rft.volume=79+%28+Pt+5%29&rft.spage=1027&rft_id=info:doi/10.1099%2F0022-1317-79-5-1027&rft_id=info%3Apmid%2F9603317&rft_id=info%3Apmid%2F9603317&rft.externalDocID=9603317 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1317&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1317&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1317&client=summon |